the FDA approved Akura Medical's IDE application to initiate the QUADRA-PE study evaluating the Katana thrombectomy system for acute pulmonary embolism (PE). . On October 1, 2024, Surmodics ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for Imperative Care’s Zoom System, marking an ...

trial evaluating the safety and efficacy of the company’s Aventus Thrombectomy System for the treatment of pulmonary embolism (PE). A total of 130 patients with intermediate-risk PE were ...

Its most serious acute complication, namely pulmonary embolus ... removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical ...

“This trial is a key step toward delivering a more streamlined, efficient, and precise thrombectomy solution for treating life-threatening blood clots,” said Dr. Jun Li, Co-Director of the Vascular ...

The prospective, multicenter CLEAN-PE study aims to evaluate the safety and efficacy of the Cleaner™ Pro Thrombectomy System for removing blood clot from the lungs in patients diagnosed with pulmonary ...

Penumbra announced that it has launched the Element vascular access system, a laser-cut hypotube sheath designed for treating ...